Kapiva raises $60M Series D to boost R&D, manufacturing, and marketing

Kapiva, a D2C ayurveda brand, raised $60M Series D funding co-led by 360 ONE Asset and Vertex Growth to strengthen R&D, manufacturing, marketing, and expand globally. Founded in 2016 by Ameve Sharma and Shrey Badhani, it offers 100+ SKUs, including a best-selling diabetes supplement. In FY24, revenue nearly doubled to INR 228.6 Cr, with losses trimmed 25.4%.